Company
Twist Bioscience Corp (TWST)
Standardized SEC financial data for Twist Bioscience Corp — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001581280 · NASDAQ · Biological Products, (No Diagnostic Substances).
Gross margin
50.7%
Operating margin
-36.2%
Net margin
-20.6%
Revenue growth (YoY)
20.3%
Return on equity
-16.4%
ROIC
-37.1%
Free cash flow
-$75.6M
Debt / equity
0.00×
Ratios for fiscal year 2025, standardized from SEC filings.
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $90.1M | $132.3M | $203.6M | $245.1M | $313.0M | $376.6M |
| Cost of revenue |
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $290.0M | $477.9M | $505.0M | $336.4M | $229.1M | $185.4M |
| Inventory |
Cash flow
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$142.3M | -$112.2M | -$124.4M | -$142.5M | -$64.1M | -$47.6M |
| Capital expenditures |
Get TWST data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/TWST/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/TWST/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"